J0750 – Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0750
- Long description
- Emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
- Short description
- Hiv prep, ftc/tdf 200/300mg
- Pricing indicator
57Other carrier priced- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 2, 2024
- Last change
- January 1, 2025 – No change
Frequently asked questions
What is HCPCS code J0750?
J0750 is a HCPCS Level II code for emtricitabine 200mg and tenofovir disoproxil fumarate 300mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv).
Does Medicare cover J0750?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0738 – Injection, lenacapavir, 1 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0739 – Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0740 – Injection, cidofovir, 375 mg
- J0741 – Injection, cabotegravir and rilpivirine, 2mg/3mg
- J0742 – Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
- J0743 – Injection, cilastatin sodium; imipenem, per 250 mg
- J0744 – Injection, ciprofloxacin for intravenous infusion, 200 mg
- J0745 – Injection, codeine phosphate, per 30 mg
- J0751 – Emtricitabine 200mg and tenofovir alafenamide 25mg, oral, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv)
- J0752 – Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0759 – Injection, clevidipine butyrate, 1 mg
- J0760 – Injection, colchicine, per 1 mg
- J0770 – Injection, colistimethate sodium, up to 150 mg
- J0775 – Injection, collagenase, clostridium histolyticum, 0.01 mg
- J0780 – Injection, prochlorperazine, up to 10 mg
- J0791 – Injection, crizanlizumab-tmca, 5 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.